TERESA MEIEROTTO: Open Payments
NPI 1932899937 · KEOKUK, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 16 payments from 7 companies in 2025. Trend: 2023 $123 · 2024 $542 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $297 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Gilead Sciences, Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Wegovy, Ozempic, CAPLYTA, Hillrom - Vest System Model 105 Home Care, UBRELVY, BREZTRI, SHINGRIX, Rybelsus.
Industry payments across IA — which companies pay providers there.
